NIVESTYM
NIVESTYM
Approved
DIN Number
02485575
Drug Class
Human
Market Date
May 11, 2020
Company
HC
Pfizer Canada Ulc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02485575
AIG Number0123525003
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D
,
Prescription
A
ATC Code
L03AA02 FILGRASTIM
Product Specifications
Dosage FormSolution
Route of AdministrationSubcutaneous
,
Intravenous
AHFS Classification20:16.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
FILGRASTIMActive
Strength: 300 MCG / 0.5 ML
Monograph: FILGRASTIM